News

The 7MM soft tissue sarcoma (STS) market is estimated to reach USD 6,465.7 million by 2030 from USD 2,943.3 million in 2019 at a CAGR of 7.4%.
Introduction The global Soft Tissue Sarcoma (STS) market has demonstrated significant growth potential, with projections estimating the market to grow at a Compound Annual Growth Rate (CAGR) of 7.4% ...
Around 15% of soft tissue sarcomas occur in the arms. People more commonly develop STS in the lower extremities of the body. STS is a rare type of cancer that develops in the soft tissues of the ...
National Clinical Trials Network (NCTN) group focused on improving outcomes for adults with cancer through multi-center clinical research, recently announced the creation of a new Sarcoma Subcommittee ...
A 25-year-old athletic woman dies of a rare bone cancer less than a year after her condition of constant back pain was misdiagnosed as sciatica. Kate Drummond, a fitness enthusiast who used to run ...
representing 0.66% of overall cancer incidence and 0.88% of overall cancer mortality 2. Standard treatment for soft tissue sarcoma includes surgery, radiation therapy and/or chemotherapy. For patients ...
Professor Lucy Chappell, chief scientific adviser at the DHSC and chief executive of the NIHR, added: “Innovations such as the miONCO-Dx blood test offer an exciting new era in cancer detection with ...
SON-1010, as explained by the National Cancer Institute, is a targeted immunotherapy ... cohort is to assess combination therapy in earlier-stage patients with [soft-tissue sarcomas], which provides ...
With her acoustic guitar slung over her neck, Ashley Martin carefully adjusted a microphone before leading the small band ...
metastatic soft tissue sarcoma (STS) at the Melbourne Theranostic Innovation Centre (MTIC) in Melbourne, Australia. ZOLAR is a first-in-human, proof-of-concept and biodistribution trial that uses ...
NICE has recommended Lilly’s new soft tissue sarcoma treatment Lartruvo for use on the NHS, only the second drug to be funded via the new Cancer Drugs Fund. Lartruvo (olaratumab) in ...
a peer-reviewed journal of the American Cancer Society. Soft tissue sarcomas are rare cancers arising all over the body, in various organs and tissues such as muscle, fat, and viscera. Most ...